Steris (Steris) Net Margin %

: 10.08% (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Steris's Net Income for the three months ended in Dec. 2023 was $141 Mil. Steris's Revenue for the three months ended in Dec. 2023 was $1,396 Mil. Therefore, Steris's net margin for the quarter that ended in Dec. 2023 was 10.08%.

The historical rank and industry rank for Steris's Net Margin % or its related term are showing as below:

STE' s Net Margin % Range Over the Past 10 Years
Min: 2.16 Med: 7.64 Max: 13.45
Current: 10.48

STE's Net Margin % is ranked better than
73.47% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs STE: 10.48

Steris Net Margin % Historical Data

The historical data trend for Steris's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Margin %

10.92

13.45

12.79

5.32

2.16

Steris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																10.18	13.52	9.62	8.59	10.08

Competitive Comparison

For the Medical Devices subindustry, Steris's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steris Net Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Net Margin % distribution charts can be found below:

* The bar in red indicates where Steris's Net Margin % falls into.

Steris Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Steris's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	107.03	/	4957.839
	=	2.16 %

Steris's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	140.743	/	1395.645
	=	10.08 %

Steris (NYSE:STE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Steris Net Margin % Related Terms

Thank you for viewing the detailed overview of Steris's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Steris (Steris) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (NYSE:STE) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

S1TE34:Brazil

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Executives

Richard C Breeden	director	100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Mohsen Sohi	director	C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Cary L Majors	officer: VP, N America Com Operations	5960 HEISLEY ROAD, MENTOR OH 44060
John Adam Zangerle	director, officer: Sr. VP, Gen Counsel, and Sec.	5960 HEISLEY ROAD, MENTOR OH 44060
Michael J Tokich	director, officer: Sr. Vice Pres., CFO	C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060
Karen L Burton	officer: VP, Controller & CAO	5960 HEISLEY ROAD, MENTOR OH 44060
Renato Tamaro	officer: V.P. & Corporate Treasurer	5960 HEISLEY ROAD, MENTOR OH 44060
Andrew Xilas	officer: SVP and GM, Dental	5960 HEISLEY ROAD, MENTOR OH 44060
Paul Edward Martin	director	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422
Julia Madsen	officer: Senior VP, Life Sciences	5960 HEISLEY ROAD, MENTOR OH 44060
David B Lewis	director
Rosebrough Walter M Jr	officer: President & CEO	5960 HEISLEY ROAD, MENTOR OH 44060